Lama

Quick links to important sections

Lama

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lama

Property Description
Active ingredient Amlodipine (as Amlodipine besylate)
Form Tablet (Oral solid formulation)
Pharmacological class Calcium Channel Blocker (CCB)
Common use Blood pressure and cardiac management
Origin Synthetic compound

What Type of Medicine is Lama (Amlodipine)?

Lama is a synthetic, prescription-only cardiovascular medication whose active ingredient is Amlodipine, typically formulated as Amlodipine besylate. This compound is classified as a long-acting Calcium Channel Blocker (CCB) of the dihydropyridine type. The medication is presented as a single-ingredient product in a solid tablet format intended for oral administration.

This specific classification means the drug primarily acts as a peripheral arterial vasodilator. Amlodipine is a primary treatment agent for hypertension and specific types of angina. This clinically recognized fact establishes the drug's role in managing persistently high blood pressure and cardiac chest pain caused by reduced blood flow to the heart. Its composition relies solely on the Amlodipine besylate active substance combined with inert solid excipients to form a stable, reliable oral formulation for adults requiring long-term vascular management.

Lama’s General Purpose and Role as a Vasodilator

The general purpose of the Lama medication is to serve as both an antihypertensive agent and an antianginal drug by promoting the relaxation and widening of the arteries throughout the body. Amlodipine achieves this by selectively inhibiting the movement of calcium ions into vascular smooth muscle cells.

This mechanism causes vasodilation, which is the widening of both the peripheral and coronary blood vessels, leading directly to a reduction in peripheral vascular resistance. Amlodipine decreases resistance to blood flow, thus reducing blood pressure. The reduction of the load on the heart promotes efficient systemic blood circulation. The essential benefit of this systemic relaxation is a stabilized circulation that effectively lowers blood pressure and simultaneously decreases the cardiac workload, a key factor in treating chronic vascular conditions.

Regulatory References

  1. NIH MedlinePlus Drug Information on Amlodipine
  2. DailyMed Amlodipine Besylate Tablet Label (NIH/NLM)
  3. EMA EPAR Product Information for Amlodipine-containing combination drug

What side effects are possible with Lama?

Lama (Amlodipine) safety information is officially classified by regulatory bodies, documenting a spectrum of possible adverse reactions that define the medicine's risk profile. The adverse effects are categorized by frequency and the body system affected, strictly following official regulatory standards.

Frequency-Classified Adverse Reactions

The most commonly reported effect, classified as Very Common (ge 1/10), is peripheral edema (swelling). Effects classified as Common (ge 1/100 to < 1/10) typically include neurological and general disorders such as headache, dizziness, sleepiness (somnolence), and fatigue, alongside cardiovascular effects like flushing and palpitations, and gastrointestinal effects like nausea and abdominal pain.

Conversely, Very Rare (< 1/10,000) documented reactions represent the lowest probability but highest-severity risk tier, including events such as hepatitis, pancreatitis, severe skin reactions like Stevens-Johnson syndrome, and serious cardiac events such as certain arrhythmias.

Safety Considerations and Restrictions

The adverse reactions are systematically grouped into System-Organ Classes (SOCs), mapping the effects across the Vascular, Nervous, Gastrointestinal, and Cardiac systems. The development of peripheral edema is noted in regulatory documents as a dose-related effect, which may be more prominent at higher concentrations.

Population-specific safety statements require cautious use in older adults and individuals with hepatic impairment due to potentially altered drug clearance. Furthermore, official prescribing information lists specific situations that contraindicate the medicine's use, including conditions such as severe hypotension, cardiogenic shock, and hemodynamically unstable heart failure.

Overdose and Emergency Response

Overdose and when to seek help

Overdosage with Lama (Amlodipine) may result in severe clinical signs derived from its core function as a potent vasodilator. The primary manifestation documented in regulatory sources is excessive peripheral vasodilatation leading to marked, prolonged systemic hypotension. This severe drop in blood pressure can cause symptoms such as dizziness and fainting (syncope), and may trigger a compensatory reflex tachycardia (rapid heartbeat).


Severe Outcomes and Emergency Action

Gross overdosage carries the risk of the condition escalating to circulatory shock, a state of life-threatening circulatory collapse that has been associated with a fatal outcome in some documented cases. In the event of a suspected overdose, immediate medical attention must be sought. Government guidance mandates that emergency services should be contacted immediately if the affected person has collapsed, had a seizure, has trouble breathing, or cannot be awakened. The national Poison Control Helpline is also cited as a resource.


Clinical Management and Constraints

Management of Amlodipine overdose requires active cardiovascular support, including frequent monitoring, elevation of the extremities, and the judicious administration of fluids and vasopressors if hypotension is persistent. No specific antidote is known. Due to the drug’s long elimination half-life, patients may require extended clinical monitoring to ensure sustained stability. Patients with hepatic impairment are noted to have prolonged drug clearance, which may increase the duration of toxic effects.

Therapeutic Uses of Lama

What Lama Treats: Main Uses and Benefits

Lama is generally used for the sustained management of chronic cardiovascular conditions, relevant across two major symptomatic domains. The medicine is commonly used to help with high blood pressure (hypertension) and certain types of angina.

Comprehensive Vascular Support

Lama is generally applied in settings where patients experience symptoms related to systemic imbalance, specifically the persistent elevation of blood pressure, a condition where functional stability becomes affected. It is relevant in conditions characterized by periods of heightened symptoms, such as Chronic Stable Angina and Vasospastic Angina. The medication is considered relevant for managing the discomfort associated with these conditions, which contributes to easing the overall symptom load and helps maintain a sense of stability when symptoms are more noticeable.

“This medication is applied across domains where additional symptomatic support is needed to help patients cope more steadily with difficult episodes.”

Quick Fact: Relief for Recurrent Chest Discomfort Lama is applicable when symptoms create noticeable functional strain due to chronic high blood pressure or recurring cardiac pain. The support provided assists the patient during episodes of heightened discomfort.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Lama? (Amlodipine)

The use of Lama is strictly governed by population eligibility rules defined in official regulatory documents (e.g., FDA, EMA SmPC).

Lama is contraindicated and must not be used by patients who have known hypersensitivity to Amlodipine or any drug in the dihydropyridine class. Absolute exclusion also applies to patients experiencing severe hypotension or cardiogenic shock.

Age-Group Eligibility and Restrictions

Age Group Eligibility Status
Adults (18+) Approved for hypertension and angina.
Children 6–17 Approved only for hypertension.
Children < 6 Safety and effectiveness not established.
Older Adults Use acceptable, but initial dosing requires caution.

Use in Specific Conditions

Patients with hepatic impairment (liver issues) require caution and may need a modified starting dose due to documented reduced clearance. The usual dose is generally recommended for those with renal impairment. Use requires careful consideration in populations with severe aortic stenosis or severe obstructive coronary artery disease.

For pregnancy, use is restricted and recommended only when the potential benefit clearly justifies the risk, as safety is not established. Since Amlodipine is excreted into human milk, nursing is generally not recommended during treatment.

What should I know about interactions with other medicines?

Amlodipine's interaction profile, as documented in regulatory sources, is primarily defined by pharmacokinetic changes related to the CYP3A4 metabolic pathway. Co-administration with strong and moderate CYP3A4 inhibitors, such as Clarithromycin or Diltiazem, is associated with a documented increase in Amlodipine plasma concentrations and systemic exposure. Conversely, combining Amlodipine with CYP3A4 inducers, such as Rifampin, may result in a reduction of Amlodipine exposure.

A key restriction noted in the official prescribing information concerns the statin Simvastatin. Due to the risk of increased Simvastatin exposure, the daily dose of Simvastatin must not exceed 20 mg when co-administered with Amlodipine. Furthermore, Amlodipine increases the systemic exposure of specific co-administered immunosuppressants, including Tacrolimus and Cyclosporine.

Pharmacodynamic interactions include the risk of an additive hypotensive effect when Amlodipine is combined with other antihypertensive agents. This enhanced blood pressure-lowering effect is also documented in relation to the consumption of alcohol. For food interactions, official documentation advises against the co-ingestion of Grapefruit or Grapefruit Juice, as it may increase Amlodipine's systemic bioavailability. No specific combinations are listed as contraindicated solely due to interaction risk, and no mandatory timing-based separation rules are documented.

Mechanism of Action

Blocking the Cholinergic Pathway to Relax Airways

Lama acts as a competitive antagonist by binding to the M3 muscarinic receptors on the airway smooth muscle. This action blocks the neurotransmitter acetylcholine from signaling muscle contraction, which interrupts the signal transduction process that normally mediates smooth muscle contraction.

Mechanistic Cascade Leading to Bronchodilation

By interrupting the M3 receptor signaling sequence, Lama prevents the intracellular events (like increased calcium) that drive muscle shortening, which initiates the process of bronchodilation. The smooth muscle relaxation is the mechanistic consequence that results in a modification of the airway's cross-sectional area and a decrease in airway wall tension.

Sustained Peripheral Modulation of Airway Tone

Lama's mechanism is characterized by its high affinity and long retention at the peripheral M3 receptors in the lungs, contributing to a prolonged functional duration of the mechanism. This action results in sustained modulation of parasympathetic tone, which influences the basal level of bronchomotor tone by reducing the magnitude of the cholinergic contractile response.

Dosage and Administration Information

How to Use Lama (Amlodipine)

Lama, which contains the active substance Amlodipine, is a medication intended for long-term, chronic management. Its usage follows a clear, label-based protocol.

Administration Protocol

The approved route of administration for Amlodipine is oral. The medication is formulated as tablets in common strengths of 2.5 mg, 5 mg, and 10 mg, and is administered once daily (q.d.). The long half-life of the drug supports this continuous 24-hour dosing schedule.

Administration is flexible: the tablets may be taken with or without food as the presence of a meal does not significantly alter the drug's absorption. Regardless of the meal timing, it is advised to maintain a consistent time of day for ingestion.

Standard Dosing and Adjustment

For most adults, the usual initial oral dose is 5 mg once daily. The dose can be gradually increased, but should not exceed the maximum recommended dose of 10 mg once daily.

Dosage adjustments require a procedural approach due to the drug's pharmacologic profile. Changes in dose should generally proceed over a period of 7 to 14 days to allow the plasma concentration to reach a steady-state before the therapeutic effect is assessed. A lower starting dose of 2.5 mg once daily is indicated for specific populations, including older adults and individuals with documented hepatic impairment.

If a dose is missed, it should be taken as soon as it is remembered on the same day. If it is close to the time for the next scheduled dose, the missed dose should be skipped, and the patient should resume their regular schedule; doubling the dose is explicitly advised against.

Recent Clinical Evidence

Clinical Evidence Overview for Lama (Amlodipine)

This overview summarizes the scientific research landscape for Lama, detailing the types of studies conducted and the areas explored, without providing clinical advice or instructions.


Evidence for High Blood Pressure (Hypertension)

Research for high blood pressure, a condition characterized by functional imbalance, primarily relies on Randomized Controlled Trials (RCTs) and large, long-term trials designed to evaluate health patterns over many years. Studies examined both short-term outcomes (4 to 12 weeks) and long-term outcomes, focusing on changes in systolic and diastolic BP and tracking event rates as monitored in studies for stroke or heart attack. Findings describe patterns observed in patient groups across these trials.


Evidence for Chronic Chest Discomfort (Angina)

Lama was studied for its application in conditions involving periods of heightened symptoms such as chronic stable angina and vasospastic angina. Trials were primarily applied in studies examining patient-reported experiences, monitoring outcomes related to physical discomfort and functional measures like exercise capacity. Substudies using vascular imaging sometimes were mixed regarding clear findings on the pattern of atherosclerotic progression.


Evidence Gaps and Special Populations

Lama was evaluated in various adult populations, including older adults and those with diabetes. However, data for certain groups remain insufficient, meaning evidence for populations like pediatric patients is limited, particularly regarding long-term event outcomes. Long-term effects are not fully established for all outcomes, and research does not determine whether an individual will respond similarly over a sustained period.

Key Studies & References

  1. NIH MedlinePlus Drug Information: Amlodipine

Frequently Asked Questions (FAQ)

Common questions about Lama (FAQ)

Q: Do the side effects of Lama generally lessen over time?

Regulatory documents note that the most common side effect, peripheral edema (swelling), is often described as being dose-related, meaning it may be more noticeable at higher concentrations. The official product information does not explicitly state whether other side effects generally lessen or resolve over a specific period of time. Persistent or worsening effects are conditions to be discussed with a treating professional.

Q: Does Lama carry any specific warnings regarding potential dependency or withdrawal symptoms?

Lama (Amlodipine) is not classified as a controlled substance in the US or similar regulatory regions. Official documentation does not list dependency or specific withdrawal syndromes as a primary warning. Discontinuation guidance is a matter for discussion between the patient and their healthcare professional.

Q: What official information is available about Lama and weight changes?

Official adverse reaction lists indicate that changes in body weight have been reported in postmarketing surveillance. Both weight gain and weight decrease are listed as less common effects in regulatory documentation for Amlodipine.

Q: Can Lama be taken with over-the-counter pain relievers like acetaminophen or ibuprofen?

Regulatory information notes that certain medications, such as Ibuprofen (a type of NSAID), can sometimes cause blood pressure to increase, potentially lessening the desired blood pressure-lowering effect of Lama. Conversely, acetaminophen (Paracetamol) is generally not listed in official sources as having a significant drug interaction with Lama.

Q: How long does it typically take for a patient to feel the effects of Lama?

Lama (Amlodipine) is characterized by a kinetic profile that leads to a gradual onset of effect. This is due to its slow interaction rate with receptors in the body. The full therapeutic effect is a clinical factor that is assessed over several weeks of consistent use.

Q: Does Lama have a pregnancy category classification, and what does it indicate?

In the US, Amlodipine is regulated under the Pregnancy and Lactation Labeling Rule (PLLR) rather than the older letter categories. Official documents restrict its use to situations where the treating clinician determines the potential benefit outweighs the risk, as safety in human pregnancy is not established.

Q: Is Lama available in a generic formulation, and what is the difference from the brand name?

The active ingredient in Lama, Amlodipine, is widely available in generic form from multiple manufacturers. Both the brand-name and generic versions contain the exact same active ingredient, strength, and dosage form, and both are required to meet the same strict quality and effectiveness standards set by regulatory agencies.

Q: What happens if a person accidentally takes a higher amount of Lama than prescribed?

Regulatory documents for Lama (Amlodipine) caution that an overdose may result in excessive peripheral vasodilation, which can cause a serious and marked drop in blood pressure (hypotension). This may also lead to a reflexive increase in heart rate (tachycardia). Official guidance indicates that in the event of a suspected overdose, prompt emergency medical attention is necessary.

Q: Does Lama contain common allergens such as lactose or gluten?

Official labeling lists the inactive ingredients, which typically include substances like microcrystalline cellulose and magnesium stearate. Specific common allergens like lactose or gluten are not usually listed among the major inactive components. For complete certainty regarding allergens, the full list of excipients in the product labeling is the definitive source.

Q: What official information is available about the effect of Lama on driving or operating machinery?

Official product information notes that some patients may experience side effects like dizziness, headache, sleepiness, or fatigue. These neurological effects are described as potentially impairing a person's ability to drive or operate heavy machinery safely. This information suggests that caution may be warranted.

Q: What official guidance is on what to do if a person experiences a potential overdose of Lama?

Official documentation states that in case of a suspected overdose, the primary recommended action is immediate contact with a poison control center. Prompt emergency medical attention is necessary.

Q: What is the typical monitoring schedule (e.g., blood tests) described for patients starting Lama?

No routine, mandatory blood tests are globally defined for all patients taking Lama. However, official warnings note that extra caution and slower dose adjustments are needed for patients with documented severe hepatic impairment (liver issues). In this population, closer monitoring is described as a factor to be considered by the prescribing professional.

Q: Does Lama have a classification as a controlled substance in the US or other regions?

Lama (Amlodipine) is not classified as a federally controlled substance in the United States or other major global regulatory regions.

Q: Is it described in official sources that Lama can cause changes in mood or behavior?

Official adverse reaction documents list several reported psychiatric effects, although they are typically rare. These include symptoms such as insomnia, nervousness, depression, anxiety, and abnormal dreams.

Q: Is it necessary to take Lama with a full glass of water, according to labeling?

Official dosing instructions state that the tablets should be taken once daily and may be taken with or without food. Regulatory labeling does not typically provide a specific instruction or requirement regarding the volume of water (e.g., a 'full glass') needed for ingestion.

How should Lama be stored and disposed of?

Storage and Handling Requirements

Amlodipine tablets (Lama) must be stored at Controlled Room Temperature, specifically between 20 C and 25 C (68 F and 77 F), with permitted excursions up to 30 C (86 F). The product must be kept in its original container and maintained tightly closed to protect it from light, excess heat, and moisture. Store the medication in a secure location, out of the sight and reach of children, as mandated by regulatory labeling.

Official Disposal Rules

The most recommended way to dispose of unused or expired Lama is through an authorized drug take-back program. If a take-back program is unavailable, the medication may be discarded with household trash by removing it from the original container and mixing it with an undesirable substance, such as used coffee grounds or dirt. The mixture should then be sealed in a bag or container before disposal. The drug should not be flushed down a toilet or drain unless specifically listed on the FDA's flush list.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lama found in:

A-Z Index: